Skip to main content
logo
Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
9.01
-0.07 (-0.77%)
Aug 14, 2026, 11:58 AM EDT - Market open

Solid Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----8.0913.62
Revenue Growth
-----40.57%-
Gross Profit
----8.0913.62
Selling, General & Admin
44.7538.8833.327.7528.9527.14
Research & Development
167.4140.3396.4376.5678.4258.74
Other Operating Expenses
----0.067.18-
Total Operating Expenses
212.15179.21129.73104.25114.5585.87
Operating Income
-212.15-179.21-129.73-104.25-106.45-72.25
Interest Income
9.929.99.477.58--
Interest Expense
0.330.2-0.34-0.44--
Other Non-Operating Income (Expense)
-5.2-5.23-4.11.120.470.07
Total Non-Operating Income (Expense)
5.054.885.038.2420.470.07
Pretax Income
-207.1-174.33-124.7-96.02-85.98-72.19
Net Income
-207.1-174.33-124.7-96.02-85.98-72.19
Net Income to Common
-207.1-174.33-124.7-96.02-85.98-72.19
Net Income Growth
------
Shares Outstanding (Basic)
11188412097
Shares Outstanding (Diluted)
11188412097
Shares Change
80.97%114.38%105.27%133.60%19.59%105.58%
EPS (Basic)
-1.91-1.99-3.06-4.83-10.10-10.14
EPS (Diluted)
-1.91-1.99-3.06-4.83-10.10-10.14
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-187.81-157.44-100.67-95.7-100.99-79.05
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.70-1.80-2.47-4.81-11.86-11.10
Gross Margin
----100.00%100.00%
Operating Margin
-----1315.20%-530.50%
Profit Margin
-----1062.28%-530.01%
FCF Margin
-----1247.74%-580.36%
EBITDA
-210.52-177.57-127.27-101.67-104.04-69.29
EBITDA Margin
-----1285.45%-508.74%
EBIT
-212.15-179.21-129.73-104.25-106.45-72.25
EBIT Margin
-----1315.20%-530.50%
SEC Filings: 10-K · 10-Q